Symptomatology and symptomatic treatment in multiple sclerosis: Results from a nationwide MS registry. (October 2019)

• Record Type: Journal Article
• Authors: Rommer, Paulus Stefan; Eichstädt, Kerstin; Ellenberger, David; Flachenecker, Peter; Friede, Tim; Haas, Judith; Kleinschnitz, Christoph; Pöhlau, Dieter; Rienhoff, Otto; Stahmann, Alexander; Zettl, Uwe Klaus
• Is Part Of: Multiple sclerosis. Volume 25:Number 12(2019)
• Page Start: 1641
• Page End: 1652
• Publication Date: 2019-10
• Subjects: Multiple sclerosis -- symptoms -- symptomatic treatment -- symptom manifestation -- disability progression; Central nervous system -- Diseases -- Periodicals; Myelin sheath -- Diseases -- Periodicals; Inflammation -- Periodicals; Multiple sclerosis -- Periodicals; Central Nervous System Diseases -- Periodicals; Demyelinating Diseases -- Periodicals; Inflammation -- Periodicals; Multiple Sclerosis -- Periodicals; Système nerveux central -- Maladies -- Périodiques; Gaine de myéline -- Maladies -- Périodiques; Inflammation (Pathologie) -- Périodiques; Sclérose en plaques -- Périodiques; Electronic journals; 616.834005
• DOI: 10.1177/1352458518799580
• Languages: English
• ISSNs: 1352-4585

Abstract

Background: Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease. Over time, symptoms accumulate leading to increased disability of patients. Objective: The objective of this article is to analyze the prevalence of symptoms and symptomatic treatment patterns in a nationwide MS registry. Methods: Data sets from 35, 755 patients were analyzed. Results: More than two-thirds of patients were women with a mean age of 46.1 (±12.8) years. Median Expanded Disability Status Score (EDSS) was 3.0. The most frequently reported symptoms were fatigue, spasticity, and voiding disorders. In patients with short disease duration, fatigue was reported most frequently. Symptomatic treatment was most common for spasticity and depression, whereas fatigue was treated only in a third of affected patients. Almost a fifth of patients with EDSS ⩽ 3.5 and neuropsychological symptoms had retired from work. Conclusion: Whereas treatment for spasticity and depression is common in our cohort, sexual dysfunction, dysphagia, cognitive dysfunction, and fatigue are treated to a far lesser extent. The need for psychological support, physical, and occupational therapy has to be recognized as neuropsychological symptoms have a great impact on retirement at an early stage. Overall symptomatic treatment rates for the most common symptoms have increased over the last years ( p < 0.001).